NasdaqCM

CHEK

NasdaqGM

CNTG

CODX

NYSE

CSTL

XETRA

DAP.DE

Milan

DIA.MI

DMTK

DRIO

NasdaqGS

DXCM

Diaceutics plc, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics plc was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

DXRX.L

Toronto

EDT.TO

Paris

ERF.PA

EXAS

FLGT

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, which incorporates various user-led improvements to its small, patented gene amplification platform for ease of use in time critical situations, and to simplify workflow, as well as for professional use in emergency healthcare settings. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for targeting various pathogens in the defense applications; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive COV19-ID Kit, an innovative rapid point-of care molecular test for COVID-19. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

GDR.L

GENE

Diagnostics & Research

Symbol	Full Name	Sector	Industry	YTD Return	10Y Return (Annualized)	Dividend Yield
CHEK	Check Cap Ltd	Healthcare	Diagnostics & Research	6.73%	—	0.00%
CNTG	Centogene N.V.	Healthcare	Diagnostics & Research	-61.58%	—	0.00%
CODX	Co-Diagnostics, Inc.	Healthcare	Diagnostics & Research	-14.29%	—	0.00%
CRL	Charles River Laboratories International, Inc.	Healthcare	Diagnostics & Research	1.28%	15.53%	0.00%
CSTL	Castle Biosciences, Inc.	Healthcare	Diagnostics & Research	-7.97%	—	0.00%
DAP.DE	Danaher Corporation	Healthcare	Diagnostics & Research	10.76%	17.97%	0.45%
DGX	Quest Diagnostics Incorporated	Healthcare	Diagnostics & Research	0.86%	11.75%	2.09%
DHR	Danaher Corporation	Healthcare	Diagnostics & Research	8.36%	23.75%	0.41%
DIA.MI	DiaSorin S.p.A	Healthcare	Diagnostics & Research	2.98%	14.17%	1.15%
DMTK	DermTech, Inc.	Healthcare	Diagnostics & Research	-64.91%	—	0.00%
DRIO	DarioHealth Corp.	Healthcare	Diagnostics & Research	-12.79%	-52.37%	0.00%
DXCM	DexCom, Inc.	Healthcare	Diagnostics & Research	11.10%	32.45%	0.00%
DXRX.L	Diaceutics plc	Healthcare	Diagnostics & Research	18.39%	—	0.00%
EDT.TO	Spectral Medical Inc.	Healthcare	Diagnostics & Research	0.00%	3.24%	0.00%
ENZ	Enzo Biochem, Inc.	Healthcare	Diagnostics & Research	-23.74%	-13.03%	0.00%
ERF.PA	Eurofins Scientific SE	Healthcare	Diagnostics & Research	-3.63%	11.51%	1.76%
EXAS	Exact Sciences Corporation	Healthcare	Diagnostics & Research	-14.52%	17.51%	0.00%
FLGT	Fulgent Genetics, Inc.	Healthcare	Diagnostics & Research	-28.26%	—	0.00%
GDR.L	genedrive plc	Healthcare	Diagnostics & Research	-24.62%	-32.74%	0.00%
GENE	Genetic Technologies Limited	Healthcare	Diagnostics & Research	-6.25%	-33.92%	0.00%

Diagnostics & Research Stock List